|Bid||0.1600 x N/A|
|Ask||0.1700 x N/A|
|Day's Range||0.1700 - 0.1700|
|52 Week Range||0.1500 - 0.6900|
|Beta (5Y Monthly)||0.56|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 27, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||0.55|
3-Year SaaS Agreement entered earlier this year Provides Clinical Trial Site Onboarding and Training to Clinical Research AssociatesRe-occurring contract as a white-labelled, bolt-on education platform for a global pharmaceutical company, supporting ...
TORONTO, ON / ACCESSWIRE / December 6, 2023 / Think Research Corporation (TSXV:THNK) ("Think" or the "Company"), a company focused on transforming healthcare through integrated digital health software solutions, today announced that on November 30, ...
Annual Recurring Revenue increased by 71% to $24.6 millionHigher Margin Software & Data Revenue represents 56% of total revenue for Q3/23TORONTO, ON / ACCESSWIRE / November 27, 2023 / Think Research Corporation (TSX.V:THNK) ("Think" or the "Company"), ...